Resilience
Tuesday, June 04, 2024
Company Presentation
Company Presentation Theater 3
Resilience is a technology-focused biomanufacturing company dedicated to broadening access to complex medicines. Founded in 2020, the company is building a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the treatments of today and tomorrow can be made quickly, safely, and at-scale. By continuously advancing the science of biopharmaceutical manufacturing and development, Resilience seeks to free its partners to focus on the discoveries that improve patients’ lives and protect biopharmaceutical supply chains against future disruptions.
Company Website:
https://resilience.com/
Lead Product in Development:
Innovative contract manufacturing and development service offerings:
- Idea to Clinic: With a goal to reduce manufacturing timelines by 30%, providing a smooth path from drug ideation through to first-in-human trials.
- Sprout Solutions: Helps nurture your drug substance from a small sprout all the way to market, giving you a transparent, partnership-minded provider who’s with you every step of the way.
- Next Door Supply Chain: Curious about partnering with a CDMO based in North America? To further enhance our supply chain solutions, we have invested in expansions at our licensed sites in Cincinnati, Ohio, and Toronto, Canada. Our network supports fill finish capacity of ~150M units which will scale to greater than 200M units by 2025.
- Auto-T: Auto-T is an end-to-end manufacturing and assay platform for LVV-based autologous CAR-T and TCR-T cell therapies containing all required regulatory support to get your clinical trial started within one year of signing on.
- SnapLVV: An off-the-shelf process to get your cell therapy ready for first-in-human studies without time-consuming de novo development.
Company HQ City
San Diego
Company HQ State
CA
Company HQ Country
United States
CEO/Top Company Official
Rahul Singhvi, SC.D., Co-founder, CEO
Development Phase of Primary Product
Other/Not Applicable
Speakers
)